ALOX12 and Alzheimer disease: Meanwhile, CYP 4F14 was inactivated in the AA CYPs pathway, which enhanced the metabolism of the ALOX12/15 pathway, resulting in the increase of 12/15-HETE and further aggravation of AD symptoms.